Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Jacquelyn Martin / AP

Attorney General Jeff Sessions suggested in a press conference on Wedenesday that the Department of Justice is looking at changing Obama-era policies that allowed states to decide what to do about marijuana despite the drug remaining illegal under federal law, according to McClatchy DC.

Why it matters: This could have a huge impact on the 6 states and D.C. which will have legalized marijuana by January, 2018. Places that have already legalized marijuana and have seen the marijuana industry boom in their states could face particularly tricky legal situations.

Key quote: "In fact, we're looking at that very hard right now, we had a meeting yesterday and talked about it at some length. It's my view that the use of marijuana is detrimental, and we should not give encouragement in any way to it, and it represents a federal violation, which is in the law and is subject to being enforced."

Meanwhile, bipartisan groups of Senators and House members have been pushing for criminal justice reform bills, which would lower minimum mandatory sentences for non-violent drug crimes. A crackdown on drug crimes is not what they're looking for from Sessions.

Go deeper

Biden Day 1 challenges: Cities getting desperate

Illustration: Aïda Amer/Axios

Dire budget problems in cities from coast to coast mean that furloughs and layoffs of essential workers could ring in the new year. So President-elect Joe Biden will face instant, high-stakes calls for relief. 

Why it matters: Suffering municipalities say there's no way they can tackle COVID-19 and all their other problems without direct and immediate aid.

The pandemic is as bad as it's ever been

Expand chart
Data: The COVID Tracking Project, state health departments; Map: Andrew Witherspoon, Sara Wise/Axios

No state in America could clear the threshold right now to safely allow indoor gatherings.

The big picture: This is bad as the pandemic has ever been — the most cases, the most explosive growth and the greatest strain on hospitals. If businesses were closed right now, it would not be safe to reopen them. And holiday travel will be risky no matter where you’re coming from or where you’re going.

Oxford University coronavirus vaccine trials show strong immune response

CSL chief scientific officer Andrew Nash with a small vial to go into the bioreactor to create 30 ml doses of the AstraZeneca vaccine on Nov. 8 in Melbourne, Australia. Photo: Darrian Traynor/Getty Images

A COVID-19 vaccine from Oxford University and AstraZeneca is safe and produces strong immune responses in older, preliminary findings of a phase two trial published in the Lancet Thursday show.

Why it matters: Coronavirus cases are soaring in the U.S. and across the world. The findings from the study of 560 healthy adults, including 240 people aged over 70, follow Pfizer's announcement Wednesday that its vaccine is 95% effective and Moderna's data released Monday showing its version has a 94.5% vaccination success rate.